Search results
Jump to navigation
Jump to search
Page title matches
- ...of blood pressure (vasoconstriction) and fluid homeostasis via the [[renin-angiotensin system]]. These include angiotensins derived naturally from precursor angio ...eased by plasma [[corticosteroid]], [[estrogen]], [[thyroid hormone]], and angiotensin II levels. Angiotensinogen has 453 [[amino acid]] residues.7 KB (972 words) - 00:36, 16 June 2008
- ...of blood pressure (vasoconstriction) and fluid homeostasis via the [[renin-angiotensin system]]. These include angiotensins derived naturally from precursor angio318 bytes (35 words) - 16:42, 14 May 2010
- #Redirect [[Angiotensin receptor]]34 bytes (3 words) - 09:36, 15 June 2008
- 12 bytes (1 word) - 16:06, 24 September 2007
- ...rigger intracellular changes influencing the behavior of cells.<ref>{{MeSH|Angiotensin receptors}}</ref> ...eceptors have a sequence identity of ~30%, but have a similar affinity for angiotensin II, their main ligand.3 KB (321 words) - 13:33, 15 June 2008
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}502 bytes (74 words) - 09:30, 15 June 2008
- Cell surface proteins that bind [[angiotensin]]s and trigger intracellular changes influencing the behavior of cells.<noi187 bytes (22 words) - 16:43, 14 May 2010
- #Redirect [[Renin-angiotensin system]]38 bytes (3 words) - 09:22, 15 June 2008
- #Redirect [[Renin-angiotensin system]]38 bytes (3 words) - 09:39, 15 June 2008
- ...]]; angiotensinogen; [[angiotensin converting enzyme]]; [[angiotensin]] I; angiotensin II; and angiotensinase."<ref name="MeSH-RAS">{{MeSH}}</ref> ...eases salt and water retention in the [[kidney]]. [[Peptidyl-dipeptidase A|Angiotensin-converting enzyme]] also breaks down [[bradykinin]], a powerful vasodilator15 KB (2,041 words) - 22:49, 6 June 2012
- 36 bytes (3 words) - 01:16, 16 June 2008
- 36 bytes (3 words) - 01:16, 16 June 2008
- #REDIRECT [[Angiotensin II receptor antagonist]]48 bytes (5 words) - 11:28, 28 June 2008
- #REDIRECT [[Renin-angiotensin system]]38 bytes (3 words) - 17:25, 2 March 2010
- #Redirect [[Angiotensin II receptor antagonist]]48 bytes (5 words) - 00:13, 18 April 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:15, 18 April 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:24, 18 April 2008
- {{r|Renin-angiotensin system}}887 bytes (140 words) - 12:56, 15 June 2008
- ...es such as losartan. Some are used as antihypertensive agents."<ref>{{MeSH|Angiotensin II Type 1 Receptor Blockers}}</ref> Inhibition of the [[renin-angiotensin system]] is used to treat [[hypertension]], [[heart failure]], and [[chroni10 KB (1,338 words) - 16:40, 10 May 2012
- ...in]]; angiotensinogen; angiotensin converting enzyme; [[angiotensin]] I; [[angiotensin]] II; and angiotensinase.<noinclude>{{DefMeSH}}</noinclude>261 bytes (27 words) - 16:43, 14 May 2010
- 36 bytes (3 words) - 01:17, 16 June 2008
- ...ld natriuresis without affecting heart rate and contractility."<ref>{{MeSH|Angiotensin-converting enzyme inhibitors}}</ref> ...n=}}</ref> This may contribute to some patients having a cough when taking angiotensin-converting enzyme inhibitors.5 KB (688 words) - 21:20, 2 September 2011
- Agents that antagonize angiotensin II type 1 receptor. Included are angiotensin II analogs such as saralasin and biphenylimidazoles such as losartan. Some261 bytes (32 words) - 16:43, 14 May 2010
- ...sion]] and [[heart failure]], by hemodynamic effect inhibiting the [[renin-angiotensin system]].169 bytes (19 words) - 09:11, 19 September 2009
- {{r|Angiotensin}} {{r|Angiotensin receptor}}1 KB (158 words) - 01:42, 16 June 2008
- 12 bytes (1 word) - 20:02, 6 December 2007
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}367 bytes (48 words) - 01:30, 16 June 2008
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}331 bytes (45 words) - 09:51, 15 June 2008
Page text matches
- ...in]]; angiotensinogen; angiotensin converting enzyme; [[angiotensin]] I; [[angiotensin]] II; and angiotensinase.<noinclude>{{DefMeSH}}</noinclude>261 bytes (27 words) - 16:43, 14 May 2010
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}367 bytes (48 words) - 01:30, 16 June 2008
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}331 bytes (45 words) - 09:51, 15 June 2008
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}502 bytes (74 words) - 09:30, 15 June 2008
- ...enzyme''' converts [[angiotensin]] I to [[angiotensin]] II in the [[renin-angiotensin system]].716 bytes (92 words) - 01:40, 16 June 2008
- ...dyl-dipeptidase A is called Angiotensin I converting enzyme in the [[renin-angiotensin system]] and Kininase II in the [[kallikrein-kinin system]].188 bytes (22 words) - 01:40, 16 June 2008
- Agents that antagonize angiotensin II type 1 receptor. Included are angiotensin II analogs such as saralasin and biphenylimidazoles such as losartan. Some261 bytes (32 words) - 16:43, 14 May 2010
- ...lood pressure]] and increase sodium retention by the kidney in the [[renin-angiotensin system]].<noinclude>{{DefMeSH}}</noinclude>328 bytes (40 words) - 16:43, 14 May 2010
- {{r|Renin-angiotensin system}} {{r|Angiotensin converting enzyme inhibitor}}553 bytes (57 words) - 11:06, 29 July 2009
- {{r|Renin-angiotensin system}} {{r|Angiotensin receptor||**}}680 bytes (81 words) - 00:02, 5 January 2010
- {{r|Renin-angiotensin system}} {{r|Angiotensin}}1,002 bytes (152 words) - 13:50, 15 June 2008
- {{r|Angiotensin receptor}} {{r|Angiotensin}}758 bytes (96 words) - 10:47, 11 January 2010
- #redirect [[Angiotensin]]25 bytes (2 words) - 08:27, 15 June 2008
- #Redirect [[Angiotensin receptor]]34 bytes (3 words) - 09:36, 15 June 2008
- #REDIRECT [[Renin-angiotensin system]]38 bytes (3 words) - 17:25, 2 March 2010
- #Redirect [[Renin-angiotensin system]]38 bytes (3 words) - 09:22, 15 June 2008
- #Redirect [[Renin-angiotensin system]]38 bytes (3 words) - 09:39, 15 June 2008
- #REDIRECT [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 08:44, 29 October 2008
- #redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 23:01, 17 April 2008
- #redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 23:01, 17 April 2008
- #Redirect [[Angiotensin II receptor antagonist]]48 bytes (5 words) - 00:13, 18 April 2008
- #REDIRECT [[Angiotensin II receptor antagonist]]48 bytes (5 words) - 11:28, 28 June 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:15, 18 April 2008
- #REDIRECT [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 08:11, 25 July 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:24, 18 April 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:25, 18 April 2008
- #Redirect [[Angiotensin-converting enzyme inhibitor]]53 bytes (4 words) - 00:25, 18 April 2008
- #redirect [[Angiotensin II receptor antagonist]]48 bytes (5 words) - 21:51, 14 May 2008
- {{r|Angiotensin}} {{r|Angiotensin receptor}}1 KB (158 words) - 01:42, 16 June 2008
- {{r|Angiotensin II receptor antagonist}} {{r|Angiotensin-converting enzyme inhibitor}}2 KB (187 words) - 17:07, 11 January 2010
- ...rigger intracellular changes influencing the behavior of cells.<ref>{{MeSH|Angiotensin receptors}}</ref> ...eceptors have a sequence identity of ~30%, but have a similar affinity for angiotensin II, their main ligand.3 KB (321 words) - 13:33, 15 June 2008
- ...sion]] and [[heart failure]], by hemodynamic effect inhibiting the [[renin-angiotensin system]].169 bytes (19 words) - 09:11, 19 September 2009
- Cell surface proteins that bind [[angiotensin]]s and trigger intracellular changes influencing the behavior of cells.<noi187 bytes (22 words) - 16:43, 14 May 2010
- ...biosynthesis or actions of [[aldosterone]], which is part of the [[renin-angiotensin system]].171 bytes (21 words) - 15:59, 24 September 2010
- ...of blood pressure (vasoconstriction) and fluid homeostasis via the [[renin-angiotensin system]]. These include angiotensins derived naturally from precursor angio318 bytes (35 words) - 16:42, 14 May 2010
- ...nase II, formally called [[peptidyl-dipeptidase A]], is the same enzyme as angiotensin converting enzyme. ...t al'' |title=Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough |journal=J Gen Intern Med |volume3 KB (401 words) - 02:34, 16 June 2008
- ...lood pressure]] and increase sodium retention by the kidney in the [[renin-angiotensin system]]."<ref>{{MeSH}}</ref>1 KB (132 words) - 01:22, 15 June 2008
- A drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment262 bytes (36 words) - 06:37, 4 January 2010
- ...renal functions. It interacts with the [[Renin-angiotensin system | renin-angiotensin-aldosterone system]] to regulate [[blood pressure]], generation of [[prosta ...nase II, formally called [[peptidyl-dipeptidase A]], is the same enzyme as angiotensin converting enzyme.1 KB (194 words) - 01:25, 16 June 2008
- ...ld natriuresis without affecting heart rate and contractility."<ref>{{MeSH|Angiotensin-converting enzyme inhibitors}}</ref> ...n=}}</ref> This may contribute to some patients having a cough when taking angiotensin-converting enzyme inhibitors.5 KB (688 words) - 21:20, 2 September 2011
- {{r|Angiotensin receptor}} {{r|Angiotensin II receptor antagonist}}1 KB (165 words) - 08:37, 18 June 2008
- ...of blood pressure (vasoconstriction) and fluid homeostasis via the [[renin-angiotensin system]]. These include angiotensins derived naturally from precursor angio ...eased by plasma [[corticosteroid]], [[estrogen]], [[thyroid hormone]], and angiotensin II levels. Angiotensinogen has 453 [[amino acid]] residues.7 KB (972 words) - 00:36, 16 June 2008
- {{r|Angiotensin}} {{r|Renin-angiotensin system}}2 KB (206 words) - 14:21, 8 March 2024
- <!--This is part of the [[renin-angiotensin system ]].-->465 bytes (54 words) - 02:04, 7 October 2013
- * {{r|Angiotensin-converting enzyme inhibitor|ACE inhibitor}}337 bytes (41 words) - 09:07, 19 September 2009
- {{r|Angiotensin receptor}}439 bytes (55 words) - 19:31, 11 January 2010
- {{r|Renin-angiotensin system}}499 bytes (61 words) - 19:26, 11 January 2010
- {{r|Angiotensin-converting enzyme inhibitor}}691 bytes (86 words) - 15:43, 11 January 2010
- {{r|Angiotensin II receptor antagonist}}661 bytes (84 words) - 10:56, 11 January 2010
- ...es such as losartan. Some are used as antihypertensive agents."<ref>{{MeSH|Angiotensin II Type 1 Receptor Blockers}}</ref> Inhibition of the [[renin-angiotensin system]] is used to treat [[hypertension]], [[heart failure]], and [[chroni10 KB (1,338 words) - 16:40, 10 May 2012
- {{r|Angiotensin}}660 bytes (85 words) - 16:54, 11 January 2010
- ...a [[base (chemistry)|base]] in chemical reactions. Some tetrazoles are [[angiotensin]] receptor antagonists used to treat high blood pressure ([[hypertension]])672 bytes (100 words) - 14:38, 6 February 2010
- {{r|Renin-angiotensin system}}1 KB (144 words) - 00:13, 21 January 2011
- ...]]; angiotensinogen; [[angiotensin converting enzyme]]; [[angiotensin]] I; angiotensin II; and angiotensinase."<ref name="MeSH-RAS">{{MeSH}}</ref> ...eases salt and water retention in the [[kidney]]. [[Peptidyl-dipeptidase A|Angiotensin-converting enzyme]] also breaks down [[bradykinin]], a powerful vasodilator15 KB (2,041 words) - 22:49, 6 June 2012
- {{r|Angiotensin}}1 KB (146 words) - 15:42, 11 January 2010
- {{r|Angiotensin II receptor antagonist}}1 KB (150 words) - 19:29, 11 January 2010
- {{r|Renin-angiotensin system}}887 bytes (140 words) - 12:56, 15 June 2008
- {{r|Renin-angiotensin system}}905 bytes (141 words) - 09:49, 15 June 2008
- {{r|Renin-angiotensin system}}900 bytes (141 words) - 01:41, 16 June 2008
- {{r|Angiotensin}}1 KB (190 words) - 04:39, 24 February 2010
- {{r|Angiotensin}}1 KB (175 words) - 08:13, 8 November 2010
- {{r|Angiotensin II receptor antagonist}}2 KB (203 words) - 11:57, 11 January 2010
- {{r|Angiotensin receptor}}2 KB (244 words) - 09:18, 6 March 2024
- {{r|Angiotensin-converting enzyme inhibitor}}2 KB (212 words) - 11:56, 11 January 2010
- [[Telmisartan]], an [[angiotensin II type 1 receptor blocker]], slows the increase in [[albuminuria]] but may2 KB (223 words) - 12:20, 18 November 2009
- {{r|Angiotensin}}2 KB (265 words) - 10:53, 11 January 2010
- ...as a result of decreased renal blood flow and this results in release of [[angiotensin II]], which stimulates aldosterone secretion. [[Adrenocorticotropic hormone4 KB (572 words) - 14:31, 4 February 2011
- Examples of G-protein-coupled receptors include [[adrenergic receptor]]s, [[angiotensin receptor]]s, [[bradykinin receptor]]s, [[CCR5 receptor]] (used by [[HIV]] t3 KB (338 words) - 13:08, 30 March 2010
- ...enylpropyl)-L-[[lysine|lysyl]]]-L-[[proline]] dihydrate, that acts as an [[angiotensin converting enzyme]] inhibitor ([[ACE inhibitor]]).2 KB (284 words) - 04:33, 14 February 2010
- ...G-protein-coupled receptor]]. Examples include [[adrenergic receptor]]s, [[angiotensin receptor]]s, [[bradykinin receptor]]s, [[CCR5 receptor]] (used by [[HIV]] t2 KB (273 words) - 11:27, 4 May 2010
- ...ic peptide causes diuresis, vasodilitation, and suppression of the [[renin-angiotensin system]] and [[sympathetic nervous system]].<ref name="pmid10911006"/>2 KB (299 words) - 21:01, 2 March 2010
- {{r|Angiotensin}}2 KB (295 words) - 10:18, 30 May 2009
- ...or= |title=Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Ant ...l| title=Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The A6 KB (806 words) - 11:51, 2 February 2023
- ...fluid and electrolyte homeostasis in particular. These peptides include [[angiotensin]], [[endothelin]], [[atrial natriuretic factor]], and [[relaxin]]. <ref>Fry3 KB (389 words) - 09:41, 23 February 2009
- ...vaneethan SD, Craig JC |title=Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney d | Angiotensin converting enzyme inhibitors<ref name="pmid17054288"/> || Diabetic renal di27 KB (3,634 words) - 21:11, 5 October 2011
- With treatment using [[angiotensin-converting enzyme inhibitor]]s, an studies find that about 40% of patients4 KB (492 words) - 21:28, 9 September 2020
- ...n of the blood, and about circulating concentrations of hormones such as [[angiotensin]] and [[relaxin]] to regulate the magnocellular neurones. Inputs from the5 KB (692 words) - 17:09, 21 March 2024
- ...rnal |author=Shekelle PG, Rich MW, Morton SC, ''et al'' |title=Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ve5 KB (679 words) - 09:15, 29 August 2009
- ...C, Kordon C (2008) Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems. ''J Neuroendocrinol'' 20279-89. PMID 181944304 KB (542 words) - 11:21, 25 May 2009
- ...s well as conventional transmitters, and, for example, [[somatostatin]], [[angiotensin]] and several [[endogenous opioids]] are active on magnocellular neurons, w ...plasma osmolality, and about circulating factors including the peptides [[angiotensin]] and [[relaxin]]. These projections include both excitatory and inhibitory11 KB (1,560 words) - 17:09, 21 March 2024
- * Hypotension associated with leukoreduced blood and maybe [[angiotensin-converting enzyme]] may cause flushing and <span style="background-color:fu6 KB (775 words) - 21:57, 14 February 2010
- ...issue expresses angiotensinogen and enzymes required for its conversion to angiotensin II] ''J Clin Endocrinol Metab'' 83:3925-9 PMID 9814470 ...s tissues by enzymes of the renin-angiotensin system (RAS) or the nonrenin-angiotensin system (NRAS)….We conclude that human adipose tissue expresses angiotensi31 KB (4,537 words) - 09:57, 18 February 2011
- ...ldosterone]]."<ref>{{MeSH}}</ref> Their actions affect the larger [[renin-angiotensin system]].6 KB (789 words) - 00:07, 21 February 2011
- ...rnal |author=Shekelle PG, Rich MW, Morton SC, ''et al'' |title=Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ve6 KB (767 words) - 17:34, 10 February 2024
- ...al| title=Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The An ...ic peptide causes diuresis, vasodilitation, and suppression of the [[renin-angiotensin system]] and [[sympathetic nervous system]].<ref name="pmid10911006"/>13 KB (1,669 words) - 07:45, 9 June 2014
- ====Angiotensin inhibition===== [[Angiotensin-converting enzyme inhibitor]] and [[angiotensin II receptor antagonist]] medications may reduce attacks according to a [[sy26 KB (3,466 words) - 20:38, 20 March 2014
- ===Angiotensin-converting enzyme inhibitors=== ...S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G| title=Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-ris31 KB (4,198 words) - 11:24, 23 July 2015
- * Inhibitors of the [[renin angiotensin system]] according to a [[meta-analysis]]<ref name="pmid21412884">{{cite jo7 KB (985 words) - 16:38, 9 September 2020
- ...creted by peripheral endocrine tissues, such as [[leptin]], [[ghrelin]], [[angiotensin]] and [[insulin]]. Also pituitary hormones, [[cytokines]], glucose and plas ...], and [[sodium appetite]]. They also contain neurons with receptors for [[angiotensin]], [[atrial natriuretic factor]], [[endothelin]] and [[relaxin]], each of w16 KB (2,283 words) - 09:06, 15 March 2011
- ...by stopping [[adrenergic beta-receptor blockader]]s (beta-blockers) and [[angiotensin-converting enzyme inhibitor]]s (ACE inhibitors).<ref name="pmid11829703"/> | [[Angiotensin-converting enzyme inhibitor|ACE inhibitors]]|| [[Systematic review]] (indi73 KB (10,150 words) - 21:46, 20 August 2014
- ...on]] is characterized by volume expansion and abnormalities of the [[renin-angiotensin system]] with high [[aldosterone]] and [[cortisol]] with low [[renin]] leve9 KB (1,159 words) - 14:09, 2 February 2023
- ...iuresis]]). Natriuretic peptides are functional antagonists to the [[renin-angiotensin-aldosterone system]]. BNP was given its name because it was first discovere11 KB (1,470 words) - 14:35, 18 March 2024
- ...up |title=Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Ant ...S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G |title=Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-ris56 KB (7,418 words) - 15:13, 5 November 2013
- ::*Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and10 KB (1,412 words) - 17:20, 20 October 2016
- ...ther environmental allergen, or physical irritation), and 11% are due to [[angiotensin-converting enzyme inhibitor]] treatment.<ref name="pmid17060655">{{cite jou13 KB (1,716 words) - 13:00, 13 June 2010
- ...tters often co-exist with various peptides - including [[somatostatin]], [[angiotensin]], [[neuropeptide Y]] and many others. Other afferent neurotransmitters inc14 KB (1,974 words) - 15:49, 13 April 2019
- ...tensin-II converting enzyme antagonists]], [[calcium channel blocker]]s, [[angiotensin-II receptor blockers]], etc.31 KB (4,786 words) - 14:28, 18 February 2024
- * [[Angiotensin]] II ''stimulates'' the secretion of vasopressin.<ref>Vander AJ ''Renal Phy15 KB (1,951 words) - 10:35, 8 August 2011
- ...a involving the respiratory is an uncommon but recognized side effect of [[angiotensin-converting enzyme inhibitor]]s.15 KB (2,125 words) - 17:43, 11 June 2010
- ====Angiotensin-converting enzyme inhibitors==== ...S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G |title=Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-ris98 KB (13,470 words) - 13:28, 10 February 2023